223

Last update : 10/20/2017

EPIREUN - Cross-sectional study of patients with newly diagnosed seizures on the island of Réunion

Head : Preux Pierre-Marie, Neuroépidémiologie tropicale

Main objective

To evaluate the incidence of seizures in Réunion's population.
To determine the risk factors specific to Réunion among epileptic patients

Inclusion criteria

- male or female
- resident of Réunion
- newly diagnosed as epileptic

Last update : 10/20/2017

- Longitudinal study of pesticide exposure in outdoor farming - Calvados

Head : Lebailly Pierre, Groupe Régional d’Études sur le Cancer

Version 1

224

Last update : 10/20/2017

- Longitudinal study of pesticide exposure in outdoor farming - Calvados

Head : Lebailly Pierre, Groupe Régional d’Études sur le Cancer

Main objective

To demonstrate the contamination of farmers who are exposed to pesticides while treating their outdoor agriculture.
To determine the link between pesticide exposure for a farmer and the probability of developing cancer.

Inclusion criteria

- male
- farmer
- using pesticides on crops

Last update : 10/20/2017

- Cross-sectional Study on The Prevalence of Allergic Rhinitis in Asthmatic People

Head : Magnan Antoine, UMR 915: l'Institut du thorax

Version 1

225

Last update : 09/05/2017

- Cross-sectional Study on The Prevalence of Allergic Rhinitis in Asthmatic People

Head : Magnan Antoine, UMR 915: l'Institut du thorax

Main objective

To describe the frequency and severity of allergic rhinitis in French asthmatic patients.

Inclusion criteria

- male and female
- adult
- asthmatic

Last update : 09/05/2017

CONSTANT - Cross-sectional study of the general population in Guadeloupe: health, behaviour and social environment.

Head : Atallah André, Cardiovascular rehabilitation unit

Version 1

226

Last update : 10/20/2017

CONSTANT - Cross-sectional study of the general population in Guadeloupe: health, behaviour and social environment.

Head : Atallah André, Cardiovascular rehabilitation unit

Main objective

To provide data concerning the health, behaviour and social environment of the Guadeloupean population

Inclusion criteria

Individuals selected randomly who agree to participate in the study

Last update : 10/20/2017

PHAPPG - Longitudinal study of a precarious Guadeloupean population: arterial hypertension study

Head : Atallah André, Cardiovascular rehabilitation unit

Version 1

227

Last update : 10/20/2017

PHAPPG - Longitudinal study of a precarious Guadeloupean population: arterial hypertension study

Head : Atallah André, Cardiovascular rehabilitation unit

Main objective

The purpose of this study is to describe the prevalence and treatment of arterial hypertension in a population that is precarious but has good social coverage and good access to the health care system

Inclusion criteria

The study's inclusion criteria for defining precarity were: receiving the minimum integration income (RMI) and/or unemployment and/or living exclusively on social and family services

Last update : 10/20/2017

BINOME - Observational study of the sociodemographic characteristics of patients infected with HIV B subtype versus HIV non-B subtype and having recently started their first course of antiretroviral treatment.

Head : Cohen-Codar Isabelle

Version 3

228

Last update : 07/01/2018

BINOME - Observational study of the sociodemographic characteristics of patients infected with HIV B subtype versus HIV non-B subtype and having recently started their first course of antiretroviral treatment.

Head : Cohen-Codar Isabelle

Main objective

Describe and compare the socio-demographic characteristics of patients infected with an HIV-1 of subtype B (group 1) compared to non-B (group 2) treated with a first anti-retroviral drug treatment.
Compare according to the HIV subtype the stage of the disease (clinical, viro-immunology, co-morbidities) at the time treatment is initiated, compare between the 2 groups (B and non-B) the conditions for taking the treatment and the perception by the patient of the therapy and of its effects.
Identification of any correlation between these latter parameters and the change in the disease between the initiation and the first line ARV and the inclusion in the cohort:
- change in the viral load (VL) according to the ARV treatment (PI, NNRTI) and of the HIV subtype (B or non-B), of the CD4,
- any occurrence of clinical events,
- any changes in treatments and reasons.

Inclusion criteria

Age > 18 years, obtaining of written consent for the collection of this personal data, patient infected by the HIV-1 virus, patient coming to consult for the first or second routine follow-up visit (i.e. 1 to 4 months) after the initiation of the ARV treatment, genotype available when the treatment is initiated.

Last update : 07/01/2018